SSII — SS Innovations International Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Market Cap
$1.20bn
Enterprise Value
$1.21bn
Revenue
$20.65m

Annual cashflow statement for SS Innovations International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1.12	-1.48	-2.21	-20.9	-19.2
Depreciation
Non-Cash Items	0.455	1.95	0.865	15.5	16
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.542	-0.85	-0.097	-10.2	-6.79
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-0.091	-0.363	-1.44	-15.4	-9.5
Capital Expenditures	-0.004	—	—	-0.453	-0.661
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.04	0.038	-3	—	—
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities	-0.044	0.038	-3	-0.453	-0.661
Financing Cash Flow Items	0.195	0.315	0	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.267	0.57	5.38	22.8	9.43
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.132	0.245	0.946	6.81	-0.464